Falcon Point Capital’s Pfizer PFE Stock Holding History

Falcon Point Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-22,362	Closed	-$594K	–	128
2013 Q2	$594K	Buy	+22,362	New	+$618K	0.65%	61

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Falcon Point Capital's PFE Position: Q3 2013 in Review

Falcon Point Capital sold out of Pfizer (PFE) in Q3 2013, closing a stake of 22,362 shares — an estimated $594K sold.

Falcon Point Capital first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $594K in Q2 2013. 1,605 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

Falcon Point Capital reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
Falcon Point Capital sold 22,362 Pfizer shares in Q3 2013, an estimated $594K.
Falcon Point Capital first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
Falcon Point Capital's Pfizer position peaked at $594K in Q2 2013.
1,605 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Falcon Point Capital's 13F filing for Q3 2013, filed 1 Nov 2013.